| mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.071 |
0.02 |
| mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.02 |
| mRNA |
AZD0530 |
FIMM |
pan-cancer |
AAC |
0.39 |
0.02 |
| mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.02 |
| mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.02 |
| mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |
| mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.02 |
| mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
| mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.03 |